- Home
- TIL vs KGEI Comparison
TIL vs KGEI Comparison
Compare TIL & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- KGEI
- Stock Information
- Founded
- TIL 2018
- KGEI 2008
- Country
- TIL United States
- KGEI United States
- Employees
- TIL N/A
- KGEI N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- KGEI
- Sector
- TIL Health Care
- KGEI
- Exchange
- TIL Nasdaq
- KGEI Nasdaq
- Market Cap
- TIL 230.1M
- KGEI 254.9M
- IPO Year
- TIL 2021
- KGEI N/A
- Fundamental
- Price
- TIL $23.14
- KGEI $6.82
- Analyst Decision
- TIL Buy
- KGEI Strong Buy
- Analyst Count
- TIL 5
- KGEI 1
- Target Price
- TIL $119.00
- KGEI $11.00
- AVG Volume (30 Days)
- TIL 387.8K
- KGEI 377.2K
- Earning Date
- TIL 08-12-2025
- KGEI 08-12-2025
- Dividend Yield
- TIL N/A
- KGEI N/A
- EPS Growth
- TIL N/A
- KGEI 42.32
- EPS
- TIL N/A
- KGEI 0.57
- Revenue
- TIL N/A
- KGEI $60,739,000.00
- Revenue This Year
- TIL N/A
- KGEI $32.19
- Revenue Next Year
- TIL N/A
- KGEI $33.24
- P/E Ratio
- TIL N/A
- KGEI $12.01
- Revenue Growth
- TIL N/A
- KGEI 20.06
- 52 Week Low
- TIL $9.62
- KGEI $2.85
- 52 Week High
- TIL $92.00
- KGEI $9.89
- Technical
- Relative Strength Index (RSI)
- TIL 43.15
- KGEI 48.00
- Support Level
- TIL $21.29
- KGEI $6.54
- Resistance Level
- TIL $31.67
- KGEI $7.08
- Average True Range (ATR)
- TIL 3.95
- KGEI 0.31
- MACD
- TIL -1.71
- KGEI -0.03
- Stochastic Oscillator
- TIL 8.60
- KGEI 28.72
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.